Semaglutide is one of the few medications where the plan is to not take the therapeutic dose on day one. Every patient starts low and climbs a fixed ladder of dose increases — called titration — over several months. Here's the standard schedule, what each rung is for, and the part most articles skip: why falling behind the label's timeline is usually the right call, not a failure.
The standard Wegovy® titration schedule
Per the FDA-approved Wegovy® prescribing information, the dose escalates every 4 weeks:
| Weeks | Once-weekly dose | Purpose |
|---|---|---|
| 1–4 | 0.25 mg | Starter dose — lets your GI tract adapt; not intended as a treatment dose |
| 5–8 | 0.5 mg | First escalation |
| 9–12 | 1 mg | Second escalation |
| 13–16 | 1.7 mg | Third escalation |
| 17+ | 2.4 mg | Standard maintenance dose |
That's a 16-week climb to maintenance if every step goes smoothly. A higher-strength option also exists: Wegovy HD® carries a 7.2 mg maximum maintenance dose, reached through additional clinician-directed escalation steps beyond 2.4 mg — whether to go there at all is a decision your prescriber makes based on your response and tolerability, not a default destination.
Why the ladder exists
Every rung serves the same purpose: GI tolerability. Semaglutide slows stomach emptying and acts on appetite-regulation pathways, and the digestive system needs time to adapt. Nausea is most common in the first 2–4 weeks at a new dose and commonly returns — briefly — after each escalation, then settles. Starting at 2.4 mg without the climb would make side effects far more likely and far less manageable.
That's also why the 0.25 mg starter dose can feel underwhelming: it's labeled as a non-therapeutic acclimation dose. Feeling only modest appetite change in month one isn't a sign the medication "isn't working" — the treatment dose simply hasn't arrived yet.
Slower than the label is normal
The 4-week cadence is the minimum interval between steps, not a deadline. In practice, many patients take 4–6 months to reach their maintenance dose, because clinicians routinely:
- Hold a dose for an extra 4 weeks when side effects haven't fully settled
- Step back down after a rough escalation, then re-attempt later
- Stop climbing early — if your appetite, progress, and side effects are all in a good place at 1 mg or 1.7 mg, there's no rule that you must reach 2.4 mg
The maintenance dose that matters is the one you can stay on comfortably. If a dose increase hits hard, tell your prescriber rather than pushing through — a slower ladder with a patient still on it beats a fast ladder they quit.
Never adjust your own titration — don't skip ahead, double a dose, or split doses to "average out" a step. Dose changes on semaglutide are prescriber decisions, and self-adjusting is the fastest route to the severe-nausea stories you've read online.
Ozempic® titrates differently
Ozempic® — semaglutide FDA-approved for type 2 diabetes — uses its own ladder: 0.25 mg for 4 weeks, then 0.5 mg, with further increases to 1 mg and a 2 mg maximum only if more glycemic control is needed. If you're comparing notes with someone on Ozempic®, their schedule and target dose are different by design.
What about compounded semaglutide?
Compounded semaglutide titration is clinician-directed and not standardized — there is no FDA label governing it, because compounded preparations are prepared per-patient and are not FDA-approved. In practice, prescribers commonly follow a conservative ladder similar to the one above, but your schedule is whatever your prescription says: follow your pharmacy instructions, and confirm with your care team before any dose change. One practical note for vial users — when your dose steps up, your vial's concentration may change too, which changes the number of units you draw. Re-run the math (or our dose calculator) at every escalation; our units-to-mg guide explains it.
If you miss a dose mid-titration
Missed doses matter more during the climb, because a long enough gap can reset your tolerance. The windows are product-specific — Wegovy®'s label gives 2 days, Ozempic®'s gives 5 — and if you've missed more than one weekly dose, contact your prescriber before restarting: they may resume your current step or drop back one rung and re-climb. Our missed-dose guide covers every scenario.
Frequently asked questions
Per the FDA-approved Wegovy® prescribing information: 0.25 mg once weekly for weeks 1–4, then 0.5 mg for weeks 5–8, 1 mg for weeks 9–12, 1.7 mg for weeks 13–16, and 2.4 mg as the standard maintenance dose from week 17 — dose increases at minimum 4-week intervals. Ozempic®, approved for type 2 diabetes, uses its own ladder (0.25 → 0.5 mg, with increases to 1 mg and a 2 mg maximum as needed). Compounded semaglutide titration is clinician-directed rather than standardized, though prescribers commonly follow a similar conservative ladder.
Sixteen weeks to the 2.4 mg maintenance dose if every step goes smoothly, per the label — but in practice many patients take 4 to 6 months, because clinicians routinely hold a dose an extra 4 weeks until side effects settle. Slower than the label is normal and often deliberate.
No — dose changes are prescriber decisions, and the 4-week minimum between steps exists because the GI side effects that make people quit are far more likely when escalation outruns the body's adjustment. Skipping ahead or doubling a dose to catch up doesn't accelerate results; it mostly accelerates nausea.
Some return of nausea after each escalation is common and typically settles as your body adjusts to the new dose. If it doesn't — or it's disrupting eating, hydration, or daily life — tell your prescriber: holding the current dose longer, or stepping back down and re-attempting later, are both routine moves. Don't push through severe symptoms silently and don't self-adjust.
No. The right maintenance dose is the one that controls appetite with side effects you can live with — for some patients that's 1 mg or 1.7 mg. If things are going well at a lower step, staying there is a legitimate clinical decision your prescriber can make with you.
Not necessarily. Compounded semaglutide has no FDA label governing titration — your schedule is set by your prescribing clinician, and while it often resembles the brand ladder, your prescription and pharmacy instructions are what govern. One practical difference for vial users: when your dose steps up, the vial concentration may change too, which changes the number of units you draw — re-check the conversion at every escalation.
References
- U.S. Food and Drug Administration. WEGOVY® (semaglutide) prescribing information. 2026.
- U.S. Food and Drug Administration. OZEMPIC® (semaglutide) prescribing information. 2026.
Bottom line: the standard semaglutide schedule is 0.25 → 0.5 → 1 → 1.7 → 2.4 mg in 4-week steps — 16 weeks by the label, 4–6 months in real life, and slower is normal. The ladder's job is to get you to a dose you can live with comfortably; how fast you climb it is your clinician's call, made with you.
A titration plan with a clinician attached
Pallas plans include ongoing check-ins and dose adjustments — message your provider any time a step feels rough.
Start your intake →